Moreover, in XLEPP (and likely EPP2), a reduction in iron availability by cimetidine might have detrimental effects: because of differences in its pathophysiology as compared to EPP1, iron supplementation is currently used to decrease blood PPIX concentration in XLEPP [46]. This evidence concerns the gene FECH and X-linked erythropoietic protoporphyria.